Pulmonary Hypertension (PH) Completed Phase 3 Trials for Sildenafil (DB00203)

Also known as: Hypertension, Pulmonary / Pulmonary; Hypertension / Pulmonary hypertension / Hypertension Pulmonary / Pulmonary hypertensions / Pulmonary hypertension NOS

IndicationStatusPhase
DBCOND0051788 (Pulmonary Hypertension (PH))Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00517933Sildenafil Trial of Exercise Performance in Idiopathic Pulmonary FibrosisTreatment
NCT00644605A Study to Assess the Efficacy and Safety of 20, 40, and 80mg of Sildenafil Three Times a Day in the Treatment of Pulmonary Arterial HypertensionTreatment
NCT00159887Study to Assess the Longterm Safety of Sildenafil Citrate in Patients With Pulmonary Arterial HypertensionTreatment
NCT00159861The Efficacy and Safety of Sildenafil Citrate Used in Combination With Intravenous Epoprostenol in PAHTreatment
NCT00454207Open Label Study of Sildenafil in Patients With Pulmonary Arterial HypertensionTreatment
NCT01726049Sildenafil in HFpEF (Heart Failure With Preserved Ejection Fraction) and PHTreatment